Health
CureVac starts clinical trial for COVID-19 vaccine candidate – Reuters India
German biotech firm CureVac has enrolled the first participant for a Phase 2b/3 clinical trial of its COVID-19 vaccine candidate, it said on Monday.
By Reuters Staff
FILE PHOTO: A vaccination against the coronavirus disease (COVID-19) from German biotechnology company CureVac is ready to use at the start of a clinical test series in the tropical institute of the university clinic in Tuebingen, Germany, June 22, 2020. REUTERS/Kai Pfaffenbach
BERLIN (Reuters) -German biotech firm CureVac has enrolled the first participant for a Phase 2b/3 clinical trial of its COVID-19 vaccine candidate, it said on Monday.
The trial, which is relevant for regulatory…
-
Noosa News21 hours agoWilliam Robinson dies aged 89
-
General21 hours agoCalls for corruption probe into completion of mayor’s Surfers Paradise Bowls Club site purchase
-
General21 hours agoMatt Wright wanted to hinder investigations into chopper crash ‘at almost any cost’, jury hears
-
Business23 hours agoTop brokers name 3 ASX shares to buy today 27 August 2025